Expansion of pulmonary CD8+CD56+ natural killer T-cells in hypersensitivity pneumonitis

Chest

Volumn 132, Issue 4, 2007, Pages 1291-1297

  Korosec, Peter ^a   Osolnik, Katarina ^a   Kern, Izidor ^a   Silar, Mira ^a   Mohorcic, Katja ^a   Kosnik, Mitja ^a  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

Hypersensitivity pneumonitis; Interstitial lung diseases; Natural killer T cells

Indexed keywords

CD14 ANTIBODY; CD16 ANTIBODY; CD161 ANTIBODY; CD3 ANTIBODY; CD4 ANTIBODY; CD45 ANTIBODY; CD56 ANTIBODY; CD8 ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGIC PNEUMONITIS; ANTIBODY DETECTION; ARTICLE; CD56+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 35448930293     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0128     Document Type: Article

References (33)

1. Norris S, Doherty DG, Collins C, et al. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells. Hum Immunol 1999; 60:20-31
2. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002; 2:557-568
3. Matsuda JL, Gapin L, Fazilleau N, et al. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size. Proc Natl Acad Sci U S A 2001; 98:12636-12641
4. Satoh M, Seki S, Hashimoto W, et al. Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol 1996; 157:3886-3892
5. Campbell JJ, Qin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001; 166:6477-6482
6. Wajchman HJ, Pierce CW, Varma VA, et al. Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin. Cancer Res 2004; 64:1171-1180
7. Sharif S, Arreaza GA, Zucker P, et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 2001; 7:1057-1062
8. Gansert JL, Kiessler V, Engele M, et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 2003; 170:3154-3161
9. Akbari O, Faul JL, Hoyte EG, et al. CD4+ invariant T-cell-receptor + natural killer T cells in bronchial asthma. N Engl J Med 2006; 354:1117-1129
10. Akbari O, Stock P, Meyer E, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003; 9:582-588
11. Lisbonne M, Diem S, de Castro Keller A, et al. Cutting edge: invariant V α 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 2003; 171:1637-1641
12. Meyer EH, Goya S, Akbari O, et al. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci U S A 2006; 103:2782-2787
13. Vijayanand P, Seumois G, Pickard C, et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 2007; 356:1410-1422
14. Ho LP, Urban BC, Thickett DR, et al. Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis. Lancet 2005; 365:1062-1072
15. ATS/ERS/WASOG Committee. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160:736-755
16. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165:277-304
17. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003; 168:952-958
18. Mermolja M, Rott T, Debeljak A. Cytology of bronchoalveolar lavage in some rare pulmonary disorders: pulmonary alveolar proteinosis and amiodarone pulmonary toxicity. Cytopathology 1994; 5:9-16
19. Semenzato G, Agostini C, Zambello R, et al. Lung T cells in hypersensitivity pneumonitis: phenotypic and functional analyses. J Immunol 1986; 137:1164-1172
20. Semenzato G, Trentin L, Zambello R, et al. Longitudinal study of alveolitis in hypersensitivity pneumonitis patients: an immunologic evaluation. J Allergy Clin Immunol 1988; 82:577-585
21. Costabel U. The alveolitis of hypersensitivity pneumonitis. Eur Respir J 1988; 1:5-9
22. Ratjen F, Costabel U, Griese M, et al. Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis. Eur Respir J 2003; 21:144-148
23. Costabel U, Bross KJ, Matthys H. The immunoperoxidase slide assay: a new method for the demonstration of surface antigens on bronchoalveolar lavage cells. Bull Eur Physiopathol Respir 1985; 21:381-387
24. Metelitsa LS. Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cells. Clin Immunol 2004; 110:267-276
25. Pittet MJ, Speiser DE, Valmori D, et al. Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. J Immunol 2000; 164:1148-1152
26. Schuyler M, Gott K, Cherne A, et al. Th1 CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis. Cell Immunol 1997; 177:169-175
27. Gudmundsson G, Hunninghake GW. Interferon-γ is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 1997; 99:2386-2390
28. Gudmundsson G, Monick MM, Hunninghake GW. IL-12 modulates expression of hypersensitivity pneumonitis. J Immunol 1998; 161:991-999
29. Yamasaki H, Ando M, Brazer W, et al. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol 1999; 163:3516-3523
30. Ohkawa T, Seki S, Dobashi H, et al. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Immunology 2001; 103:281-290
31. Oshima M, Maeda A, Ishioka S, et al. Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases. Lung 1999; 177:229-240
32. Katchar K, Soderstrom K, Wahlstrom J, et al. Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J 2005; 26:77-85
33. Papakosta D, Kyriazis G, Gioulekas D, et al. Variations in alveolar cell populations, lymphocyte subsets and NK-cells in different stages of active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:21-26